| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 07/08/2004 | WO2004011603A3 Functional cardiomyocytes from human embryonic stem cells |
| 07/08/2004 | WO2004010107A3 Method for determining the regulation of xenobiotic removal |
| 07/08/2004 | WO2004010105A3 Photonic signal reporting of electrochemical events |
| 07/08/2004 | WO2004009759A9 Novel proteins in enteroaggregative escherichia coli (eaec) useful for diagnosis and therapy of eaec infections |
| 07/08/2004 | WO2004005887A3 Methods and compositions for the detection of pregnancy in ruminants |
| 07/08/2004 | WO2004001418A3 Method for identifying and extracting endotoxin |
| 07/08/2004 | WO2003104421A3 Immunocapture and functional assay for mitochondrial f1/f0 atpase |
| 07/08/2004 | WO2003104259A3 PEPTIDES PRESENTED BY HLA-B18 AND Cw16 MOLECULES, AND USES THEREOF |
| 07/08/2004 | WO2003098183A3 Broad spectrum optically addressed sensor |
| 07/08/2004 | WO2003097872A3 G - protein coupled receptor marker molecules associated with colorectal lesions |
| 07/08/2004 | WO2003076899A3 Assays for identifying ubiquitin agents and for identifying agents that modify the activity of ubiquitin agents |
| 07/08/2004 | WO2003069331A8 Method for casein determination in milk |
| 07/08/2004 | WO2003066822A3 Truncated aggrecanase molecules |
| 07/08/2004 | WO2003062790A3 Solid phases optimized for chemiluminescent detection |
| 07/08/2004 | WO2003052633A3 Method for annotating protein sequences |
| 07/08/2004 | WO2003047331A3 Methods and apparatus for cell based screening |
| 07/08/2004 | WO2003042358A3 Methods of using 48149, a human aminopeptidase family member |
| 07/08/2004 | WO2003021225A3 Method for classification of anti-psychotic drugs |
| 07/08/2004 | WO2002097415A3 Analytical instruments, biosensors and methods |
| 07/08/2004 | WO2002097060A3 Carbohydrate-associated proteins |
| 07/08/2004 | WO2002095058A3 Emission ratiometric indicators of phosphorylation |
| 07/08/2004 | WO2002090926A3 Dose response-based methods for identifying receptors having alterations in signaling |
| 07/08/2004 | WO2002088376A3 Multiple simultaneous antigen detection by immunohistochemistry |
| 07/08/2004 | WO2002079514A9 Dna-bridged carbon nanotube arrays |
| 07/08/2004 | WO2002061412A3 Electromagnetic analysis of concrete tensioning strands |
| 07/08/2004 | WO2001022916A3 Novel hev antigenic peptide and methods |
| 07/08/2004 | US20040133933 Medane genes and proteins |
| 07/08/2004 | US20040133359 Method and system for evaluation of electrical conductivity of dna sequences |
| 07/08/2004 | US20040133356 Three-dimensional model of a Fc region of an IgE antibody and uses thereof |
| 07/08/2004 | US20040133355 Methods and compositions utilizing evolutionary computation techniques and differential data sets |
| 07/08/2004 | US20040133352 Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles |
| 07/08/2004 | US20040133348 Surface acoustic wave sensor |
| 07/08/2004 | US20040133313 Method for analyzing readings of nucleic acid assays |
| 07/08/2004 | US20040133146 Device for treating a fluid-like sample such as a whole blood, with treatment fluid, use of such a device and kit containing such a device |
| 07/08/2004 | US20040133116 Device and method for the quantitive determination of nitrogen oxides in exhaled air and application thereof |
| 07/08/2004 | US20040133114 Zebrafish Assay |
| 07/08/2004 | US20040133090 Sanitary article for an organism state analysis and a method of an organism state analysis |
| 07/08/2004 | US20040132981 modified ligands that bind irreversibly to their cognate receptors; assay for investigating protein function and as drugs for more effectively inhibiting or stimulating cognate receptor function |
| 07/08/2004 | US20040132973 for gene therapy and vaccination; enzyme-linked immunosorbent assay (ELISA); kits; genetic engineering |
| 07/08/2004 | US20040132824 Novel methods and compositions for alleviating pain |
| 07/08/2004 | US20040132803 compound having a slowly-inactivating A-type K+ channel opening activity, particularly N-(5,5-dioxido-10-oxo-4,10-dihydrothieno[3,2-c][1]benzothiepin-9-yl)-3,3,3-trifluoro-2-hydroxy-2-methylpropanamide |
| 07/08/2004 | US20040132783 Method of examining effect of angiogenesis inhibitors mediated by the inhibition of integrin expression |
| 07/08/2004 | US20040132680 Beta secretase transgenic organisms and methods of use thereof |
| 07/08/2004 | US20040132660 PRO256 polypeptide; wound healing and anticarcinogenic agents; cardiovascular disorders, atherosclerosis, and cardiac hypertrophy treatment |
| 07/08/2004 | US20040132652 Liposome associated to Neisseria meningitis polypeptide fragments or DNA fragments; prevention or diagnosis of infection |
| 07/08/2004 | US20040132646 Identification of a novel glutamine transporter |
| 07/08/2004 | US20040132638 Administering modified hemoglobins comprising nitrosylhemoglobin, nitrosyl-heme, metal substituted heme iron, or nitrosyl-porphyrin; vasodilation; anticoagulants; synthetic blood |
| 07/08/2004 | US20040132637 Administering phenylalanine-methionine-arginine-phenylalaninamide tetrapeptide; drug screening for analgesics |
| 07/08/2004 | US20040132635 Method for prevention and treatment of kidney diseases |
| 07/08/2004 | US20040132633 Using direct search algorithm moving away from a vertex which represents a least desirable dose combination; data processing, mathematics, computers |
| 07/08/2004 | US20040132220 Diagnostic instruments and methods for detecting analytes |
| 07/08/2004 | US20040132219 Using dry analysis element comprising colloidal metals to detcet, quantify and characterize preferential analytes in fluids; immunoassay |
| 07/08/2004 | US20040132217 Colorimetric sensors constructed of diacetylene materials |
| 07/08/2004 | US20040132215 Solid phase assay for detection of ligands |
| 07/08/2004 | US20040132214 Apparatus which utilizes colorimetric resonant reflectance to determining and monitoring cell interactions; high throughput assay |
| 07/08/2004 | US20040132213 Transcobalamin ll assay method |
| 07/08/2004 | US20040132212 Using immobilized ligand peptide to monitor protein, lipids, sugars and metabolite levels and their modifications in single living cells |
| 07/08/2004 | US20040132211 Isolation and confirmation of analytes from test devices |
| 07/08/2004 | US20040132210 Assay method using a biochemical analysis unit and biochemical analysis apparatus |
| 07/08/2004 | US20040132208 Using hollow membrane filter to separate and isolate preferential macromolecules from fluid mixtures; microfluidics; flow cytometry |
| 07/08/2004 | US20040132207 Method for stabilizing blood, serum, or plasma specimen and container containing pH buffer agent |
| 07/08/2004 | US20040132205 Method and apparatus for aligning microbeads in order to interrogate the same |
| 07/08/2004 | US20040132203 Method for improving a reading resolution of a biosensor |
| 07/08/2004 | US20040132202 Ammonia sensor |
| 07/08/2004 | US20040132200 Fluorescent creatinine assay |
| 07/08/2004 | US20040132198 Using microporous hollow fiber membranes to remove interferants from automated preparations of erythrocytes, enhancing sensitivity of blood cells analysis |
| 07/08/2004 | US20040132193 Method of performing calibration and quality control of a sensor and apparatus for performing the method |
| 07/08/2004 | US20040132180 Expression vector coding reporter protein for use as diagnostic tool in gene transformation analysis |
| 07/08/2004 | US20040132173 Optical microarray apparatus comprised of immobilized cells for concurrent monitoring of responses to test compounds; rational drug design and screening |
| 07/08/2004 | US20040132172 Optical apparatus comprising reflective two-dimensional grid for detecting biomolecular interactions; biosensors; medical diagnostics |
| 07/08/2004 | US20040132170 Microfluidic device and method with trapping of sample in cavities having lids that can be opened or closed |
| 07/08/2004 | US20040132169 Device and method for analyte sensing |
| 07/08/2004 | US20040132163 Biological materials and uses thereof |
| 07/08/2004 | US20040132161 Methods and compositions for increasing CD4lymphocyte immune responsiveness |
| 07/08/2004 | US20040132159 Novel beta-secretase and modulation of beta-secretase activity |
| 07/08/2004 | US20040132141 Using peripheral blood lymphocytes to generate immunoglobulins for treatment of cell proliferative disorders; immunotherapy; tissue targeted therapy |
| 07/08/2004 | US20040132139 Comprises nucleotide sequences coding protein with antiproliferative and viricidal activity for use in treatment and prevention of cancer, nervous system, bone and autoimmune disorders |
| 07/08/2004 | US20040132137 Thyroid glycoprotein horomone for treatment and prevention of hyperthyroidism and graves' disease |
| 07/08/2004 | US20040132132 Isolating, transforming and expression of vaccinia viral antigen sequences in bacteria for use as tool in development of serodiagnostic agents and vaccines |
| 07/08/2004 | US20040132131 Methods for comparitive analysis of carbohydrate polymers and carbohydrate polymers identified using same |
| 07/08/2004 | US20040132128 Using immobilized chemoattractants to monitor cell receptor-ligand interactions; bioassay |
| 07/08/2004 | US20040132125 Method for identifying phosphoprotein |
| 07/08/2004 | US20040132124 Neuroprotection by inhibition of diacyglycerol kinase epsilon activity |
| 07/08/2004 | US20040132123 Using haparinase expression to evaluate and prognose blood disorders; noninvasive immunoassay |
| 07/08/2004 | US20040132122 Multianalyte molecular analysis using application-specific random particle arrays |
| 07/08/2004 | US20040132121 Method of identifying antibacterial compounds |
| 07/08/2004 | US20040132120 Cell regulatory genes, encoded products, and uses related thereto |
| 07/08/2004 | US20040132119 Method for detecting gynecological cancers |
| 07/08/2004 | US20040132118 Using sugar chains composition expressed at non-reducing termini of asparagine linked glycoproteins to detect, classify and prognose cell proliferative disorders |
| 07/08/2004 | US20040132117 Immunoassay and diagnostic reagent for malaria |
| 07/08/2004 | US20040132116 Products and methods for single parameter and multiparameter phenotyping of cells |
| 07/08/2004 | US20040132115 Method for screening compounds for alpha1B adrenergic receptor antagonist and analgesic activity |
| 07/08/2004 | US20040132113 Corelating polymorphism within cell cycle regulatory gene and nervous system disorders; detecting aberration in rapid cell cycle arrest and re-differentiation |
| 07/08/2004 | US20040132112 Using transgenic cell coated microbead matrix for screening monoclonal antibodies and monoclonal antibody-producing cells; isolation of immunotherapeutic agents |
| 07/08/2004 | US20040132111 Diagnosing oxidative stress in a patient via detection of oxidized or nitrated cytoskeletal proteins in tissues; immunoassay |
| 07/08/2004 | US20040132110 Method for diagnosing chronic intestinal inflammatory diseases |
| 07/08/2004 | US20040132109 Using western blot or immunoassay for noninvasive detection/identification of the presence of prions in a tissue/organ; diagnosing spongiform encephalopathy, scrapie of sheep and creutzfeldt-jakob diseases |
| 07/08/2004 | US20040132108 Using mimetic peptide to identify modulators for treatment and prevention of cell proliferative and ischemic injuries/disorders |
| 07/08/2004 | US20040132107 Generation of transgenic insect cells for use as diagnostic tools in monitoring interactions between cell membrane protein and ligands |
| 07/08/2004 | US20040132106 Using immunoreactive patterns to diagnose microbial infections; skin disorders |